| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 2,765,000 | 2,749,000 | 2,649,000 | 2,518,000 | | Cost of Revenue | 2,378,000 | 2,369,000 | 2,295,000 | 2,163,000 | | | Gross Profit | 387,000 | 380,000 | 354,000 | 355,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 154,000 | 159,000 | 150,000 | 147,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 233,000 | 221,000 | 204,000 | 208,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,000 | (1,000) | 4,000 | (8,000) | | Earnings Before Interest And Taxes | 236,000 | 221,000 | 208,000 | 200,000 | | Interest Expense | 19,000 | 19,000 | 19,000 | 19,000 | | Income Before Tax | 217,000 | 202,000 | 189,000 | 181,000 | | Income Tax Expense | 82,000 | 77,000 | 72,000 | 62,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 135,000 | 125,000 | 117,000 | 119,000 | | | Non-recurring Events | | Discontinued Operations |
-
| (2,000) | (1,000) | 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 135,000 | 123,000 | 116,000 | 120,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $135,000 | $123,000 | $116,000 | $120,000 |
|
0.51% Nasdaq 
0.09 (0.47%) 
Income Statement
